scholarly journals Analysis of Lung Imaging Intelligent Diagnosis System for Nursing Intervention of Lung Cancer Patients’ Quality of Life

2021 ◽  
Vol 2021 ◽  
pp. 1-7
Author(s):  
Ruxia Guo ◽  
Hui Wang

In order to explore the influence of intelligent imaging diagnosis systems on comprehensive nursing intervention for patients with late-stage lung cancer, the system uses ITK and VTK toolkit to realize image reading, display, image marking, and interactive functions. The optimal threshold method and regional connectivity algorithm were used to segment the lung region, and then, the cavity filling algorithm and repair algorithm were used to repair the lung region. A variable ring filter was used to detect suspected shadows in the lungs. Finally, the classifier proposed in this paper is used to classify benign and malignant. The system has good sensitivity by detecting the images of real patients. 100 patients with advanced lung cancer were randomly divided into control group and nursing intervention group 50 cases each. Patients in the control group received routine radiotherapy and chemotherapy and routine nursing intervention. Patients in the nursing intervention group were given comprehensive nursing intervention on the basis of routine intervention in the control group for 2 consecutive months. Pittsburgh sleep quality index, pain degree, quality of life, and complications after intervention were compared between the 2 groups before and after intervention. The experimental results showed that the sleep quality, pain degree, quality of life, and complications in 2 groups were significantly improved after intervention ( P < 0.05 ), and the improvement degree in the nursing intervention group was higher than that in the control group ( P < 0.05 ). It is proved that comprehensive nursing intervention has a good effect on improving sleep quality, relieving physical pain, improving the quality of life, and reducing complications of lung cancer patients and can effectively improve the quality of life of lung cancer patients.

2018 ◽  
Vol 109 (6) ◽  
Author(s):  
Huihong Wang ◽  
Ying Chen ◽  
Danfeng Gu ◽  
Yuan Qian ◽  
Fang Shao ◽  
...  

2021 ◽  
pp. 1-8
Author(s):  
Silke Schibel ◽  
Marie Steinert ◽  
Harald Matthes ◽  
Christian Grah

<b><i>Background:</i></b> Lung cancer is the oncological disease with the highest mortality worldwide. Health-related quality of life is severely compromised in the majority of patients. While the efficacy of early palliative psychosocial therapy has been demonstrated in several recent studies, appropriate therapy modules could so far not be integrated into daily practice of care. Therefore, an additive multimodal treatment concept for oncological centers was drafted: the Additive anthroposophic integrative medicine Cancer Concept of Early supportive or Palliative lung cancer Treatment (ACCEPT®). <b><i>Patients and</i></b> <b><i>Methods:</i></b> The first module consisted of a 3-month health education program, the second module was a concept of psychosocial interventions, and the third module was a supervised home training program. Between 2017 and 2018, 20 lung cancer patients (UICC IIIB/IV) were included and randomly assigned to treatment (<i>n</i> = 10) or a waiting control group (<i>n</i> = 10). The treatment group started ACCEPT® for 3 months immediately after diagnosis and received also standard oncological care (SOC) while the waiting control group received SOC only for 3 months, followed by ACCEPT® after this period. Health-related quality of life, disease management, disease-specific symptoms, and feasibility of the ACCEPT® were monitored at 4 time points. <b><i>Results:</i></b> 7 out of 10 patients in the treatment group (3 dropped out) and 6 out of 10 in the waiting control group (4 died during the intervention) completed treatment. <b><i>Discussion/Conclusion:</i></b> Lung cancer patients with high symptom load may benefit from ACCEPT®. The feasibility of this adjunctive therapy was demonstrated. The combination of SOC and ACCEPT® is feasible and applicable to a heterogeneous patient group and should be further evaluated with respect to efficacy and dosing.


Author(s):  
Lorenzo Anelli ◽  
Alessia Di Nardo ◽  
Massimo Bonucci

Abstract Introduction A retrospective clinical study was performed to identify the characteristics of patients with lung cancer treated with integrative cancer treatment in addition to conventional medicine. Materials and Methods We reviewed medical records for lung cancer patients who visited a single integrative setting in Rome, Italy. A total of 57 patients were included, and the majority had advanced-stage cancer. All of them underwent integrative therapy with nutrition and phytotherapy indications. The diet was designed to reduce most of possible factors promoting cancer proliferation, inflammation, and obesity. Foods with anti-inflammatory, prebiotic, antioxidant, and anticancer properties had been chosen. Herbal supplements with known effects on lung cancer were prescribed. In particular, astragal, apigenine, fucosterol, polydatin, epigallocatechin gallate, cannabis, curcumin, and inositol were used. Furthermore, medical mushrooms and other substances were used to improve the immune system and to reduce chemotherapy side effects. Five key parameters have been evaluated for 2 years starting at the first surgery: nutritional status, immune status, discontinuation of therapy, quality of life, and prognosis of the disease. Results A relevant improvement in parameters relative to nutritional status, immune status, and quality of life has been observed after integrative therapy compared with the same parameters at the first medical visit before starting such approach. Conclusion The results suggest that integrative therapy may have benefits in patients with lung cancer. Even though there are limitations, the study suggests that integrative therapy could improve nutritional status and quality of life, with possible positive effect on overall survival.


2012 ◽  
Vol 15 (7) ◽  
pp. A430
Author(s):  
L.M. Wintner ◽  
A. Zabernigg ◽  
J.M. Giesinger ◽  
M. Sztankay ◽  
K. Gattringer ◽  
...  

Lung Cancer ◽  
2008 ◽  
Vol 62 (3) ◽  
pp. 391-400 ◽  
Author(s):  
Mei-Ling Chen ◽  
Chih-Teng Yu ◽  
Chien-Hui Yang

Sign in / Sign up

Export Citation Format

Share Document